Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Mutations found in cancer patients compromise DNA binding of the winged helix protein STK19

    Serine/threonine protein kinase 19 (STK19) has been reported to phosphorylate and activate oncogenic NRAS to promote melanomagenesis. However, concerns have been raised about whether STK19 is a kinase. STK19 h...

    Jian Li, **nli Ma, **aoyu Wang, **aotong Hu, Shaobo Fang, Guoguo ** in Scientific Reports (2024)

  2. Article

    Open Access

    Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma

    Esophageal squamous cell carcinoma (ESCC) is one of the leading causes of digestive system tumor related death in the world. Unfortunately, effective chemopreventive agent is lack for patients with ESCC in cli...

    Qiang Yuan, Yunshu Shi, Yuhan Zhang, Yaqian Shi in Cancer Cell International (2024)

  3. Article

    Open Access

    Protein translation: biological processes and therapeutic strategies for human diseases

    Protein translation is a tightly regulated cellular process that is essential for gene expression and protein synthesis. The deregulation of this process is increasingly recognized as a critical factor in the ...

    Xuechao Jia, **nyu He, Chuntian Huang, Jian Li in Signal Transduction and Targeted Therapy (2024)

  4. Article

    Open Access

    Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

    Signal transducer and activator of transcription 3 (STAT3) is a transcriptional factor involved in almost all cancer hallmark features including tumor proliferation, metastasis, angiogenesis, immunosuppression...

    Yamei Hu, Zigang Dong, Kangdong Liu in Journal of Experimental & Clinical Cancer Research (2024)

  5. Article

    Open Access

    Targeting CRAF kinase in anti-cancer therapy: progress and opportunities

    The RAS/mitogen-activated protein kinase (MAPK) signaling cascade is commonly dysregulated in human malignancies by processes driven by RAS or RAF oncogenes. Among the members of the RAF kinase family, CRAF plays...

    Penglei Wang, Kyle Laster, Xuechao Jia, Zigang Dong, Kangdong Liu in Molecular Cancer (2023)

  6. No Access

    Article

    OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer

    Oxidative stress induced growth inhibitor 1 (OSGIN1) regulates cell death. The role and underlying molecular mechanism of OSGIN1 in non-small cell lung cancer (NSCLC) are uncharacterized.

    **aomeng **e, Kyle Vaughn Laster, Jian Li in Cellular and Molecular Life Sciences (2023)

  7. Article

    Open Access

    Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer

    Esophageal squamous precancerous lesions (ESPL) are the precursors of esophageal squamous cell carcinoma (ESCC) including low-grade and high-grade intraepithelial neoplasia. Due to the absence of molecular ind...

    Xuejiao Liu, Simin Zhao, Keke Wang, Liting Zhou, Ming Jiang in Nature Communications (2023)

  8. No Access

    Article

    PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription

    Colorectal cancer (CRC) is a highly aggressive cancer in which metastasis plays a key role. However, the mechanisms underlying metastasis have not been fully elucidated. Peroxisome proliferator-activated recep...

    Wei Chen, Qiushuang Zhang, **aoshuo Dai, **nhuan Chen, Chengjuan Zhang in Oncogene (2023)

  9. No Access

    Article

    NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway

    Esophageal squamous cell carcinoma (ESCC) is a common malignancy worldwide with a low survival rate due to a lack of therapeutic targets. Here, our results showed that nuclear mitotic apparatus protein 1 (NUMA...

    Shuying Yin, Simin Zhao, Jian Li, Kangdong Liu in Cellular and Molecular Life Sciences (2023)

  10. No Access

    Article

    Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin

    Cisplatin (CDDP) is the first-line drug in the clinical treatment of esophageal squamous cell carcinoma (ESCC), which has severe nephrotoxicity. Diosmetin (DIOS) can protect kidney from oxidative damage, howev...

    Yihuan Chen, **aoshuo Dai, Wei Chen, Yan Qiao, Ruihua Bai, **aoxuan Duan in Oncogene (2023)

  11. Article

    Open Access

    TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway

    T-LAK-originated protein kinase (TOPK), a dual specificity serine/threonine kinase, is up-regulated and related to poor prognosis in many types of cancers. Y-box binding protein 1 (YB1) is a DNA/RNA binding pr...

    Wenjie Wu, Jialuo Xu, Dan Gao, Zhenliang **e, Wen**g Chen in Cell Death & Disease (2023)

  12. No Access

    Article

    New perspectives for targeting therapy in ALK-positive human cancers

    Anaplastic lymphoma kinase (ALK) is a member of the insulin receptor protein-tyrosine kinase superfamily and was first discovered in anaplastic large-cell lymphoma (ALCL). ALK alterations, including fusions, o...

    Simin Zhao, Jian Li, Qingxin **a, Kangdong Liu, Zigang Dong in Oncogene (2023)

  13. Article

    Open Access

    CAFrgDB: a database for cancer-associated fibroblasts related genes and their functions in cancer

    As one of the most essential components of the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) interact extensively with cancer cells and other stromal cells to remodel TME and participate i...

    Qiang Yuan, Yi Chu, **aoyu Li, Yunshu Shi, Yingying Chen, Jimin Zhao in Cancer Gene Therapy (2023)

  14. Article

    Open Access

    Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC

    Gastric cancer is the fourth leading cause of cancer deaths worldwide. Most patients are diagnosed in the advanced stage. Inadequate therapeutic strategies and the high recurrence rate lead to the poor 5-year ...

    Mingzhu Li, Lina Duan, Wenjie Wu, Wen**g Li, Lili Zhao, Ang Li, Xuebo Lu in Oncogenesis (2023)

  15. Article

    Open Access

    Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth

    Although molecular targets such as HER2, TP53 and PIK3CA have been widely studied in esophageal cancer, few of them were successfully applied for clinical treatment. Therefore, it is urgent to discover novel a...

    Xuechao Jia, Penglei Wang, Chuntian Huang in Journal of Experimental & Clinical Cancer … (2023)

  16. No Access

    Article

    Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma

    Targeted therapy attempts are needed to enhance esophageal squamous cell carcinoma (ESCC) patients’ overall survival and satisfaction of life. Nuclear factor erythroid 2-related factor 2 (NRF2), as a high-conf...

    **nyu He, Yubing Zhou, Wen**g Chen, **aokun Zhao, Lina Duan, Hao Zhou in Oncogene (2023)

  17. No Access

    Article

    Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma

    Esophageal squamous cell carcinoma (ESCC) is one of the leading causes of cancer death worldwide. It is urgent to develop new drugs to improve the prognosis of ESCC patients. Here, we found benzydamine, a loca...

    Yubing Zhou, **nyu He, Yanan Jiang, Zitong Wang, Yin Yu, Wenjie Wu in Frontiers of Medicine (2023)

  18. Article

    Open Access

    Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2

    Constitutive activation of RAS-RAF-MEK-ERK signaling pathway (MAPK pathway) frequently occurs in many cancers harboring RAS or RAF oncogenic mutations. Because of the paradoxical activation induced by a single...

    Penglei Wang, Xuechao Jia, Bingbing Lu in Signal Transduction and Targeted Therapy (2023)

  19. Article

    Open Access

    Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1

    Esophageal squamous cell carcinoma (ESCC) is an upper gastrointestinal cancer with high morbidity and mortality. New strategies are urgently needed to prolong patients’ survival. Through screening FDA-approved...

    **nning Liu, Yanan Jiang, Hao Zhou, **aokun Zhao, Mingzhu Li in Cell Death & Disease (2023)

  20. Article

    Open Access

    Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19

    Ning Lu, Tingxuan Gu, Xueli Tian, Simin Zhao in Signal Transduction and Targeted Therapy (2022)

previous disabled Page of 3